Literature DB >> 35083734

Exploring EQ-5D-Y-3L Experience-Based VAS Values Derived Among Adolescents.

Mimmi Åström1,2,3, Ola Rolfson4,5, Kristina Burström4,6.   

Abstract

OBJECTIVES: The EQ-5D-Y-3L is a generic health-related quality of life (HRQoL) instrument, developed from the adult version to be suitable for children and adolescents aged 8-15 years. To derive values for the EQ-5D-Y-3L different valuation methods and perspectives have been applied. The aim of this study was to explore EQ-5D-Y-3L experience-based visual analogue scale (VAS) values derived among adolescents.
METHODS: Data were derived from a cross-sectional population survey administered via schools in 2014 to adolescents aged 13-18 years, in Sweden. Regression analyses were performed on individual data with the VAS value as dependent variable. Ordinary least-squares (OLS) and generalised linear models (GLM) were estimated with two dummy variables for each of the EQ-5D-Y-3L dimensions. Interaction variables were tested. One way of anchoring VAS at dead and full health by using the predicted values for worst and best health states defined by the EQ-5D-Y-3L descriptive system was explored.
RESULTS: Of the 243 possible health states in EQ-5D-Y-3L, 92 were reported by the 6,468 respondents. The largest decrements in VAS values were observed for the dimension 'feeling worried, sad or unhappy' followed by 'doing usual activities'. All models performed similarly in terms of monotonicity and goodness of fit but in terms of simplicity and understandability, the OLS main effect model was superior.
CONCLUSIONS: We have explored experience-based VAS values for the EQ-5D-Y-3L derived among adolescents. The findings suggest that it is possible for adolescents to value their own health state using the VAS, which makes it possible to capture aspects that are important for young people.
© 2022. The Author(s).

Entities:  

Mesh:

Year:  2022        PMID: 35083734      PMCID: PMC9021108          DOI: 10.1007/s40258-021-00713-w

Source DB:  PubMed          Journal:  Appl Health Econ Health Policy        ISSN: 1175-5652            Impact factor:   3.686


Key Points for Decision Makers

Introduction

The EQ-5D is a widely used generic health-related quality of life (HRQoL) instrument, which defines health status in five dimensions and is used in population health studies, clinical studies, as well as in health technology assessment [1]. The youth version of the instrument is the EQ-5D-Y-3L, which was developed in 2009. It generates 243 health profiles or health states by combining the five dimensions and the three severity levels for each dimension [2, 3]. Health outcomes measures, such as the EQ-5D, are essential to combine length of life and HRQoL into quality-adjusted life years (QALYs), the outcome used in cost-utility analysis [4]. To enable this, a value, i.e., a QALY weight, for each of the health states needs to be obtained. In determining such values, the most used direct valuation methods for adults are the Time-Trade Off (TTO), Standard Gamble (SG), Visual Analogue Scale (VAS), Discrete Choice Experiment (DCE), and Best-Worst Scaling methods (BWS) [4-6]. When asking children and adolescents to value health states both DCE and BWS have previously been used, but the SG and TTO have been questioned [6, 7]. When using the VAS as a valuation method, respondents are asked to record a value for health states on a scale commonly numbered 0–100. The VAS has been emphasised as a simple and low-cost valuation method [8] that is easy to understand [4, 5]. However, when using the VAS as a valuation method, the choice is not made under uncertainty, but whether VAS is a choice-based method has been discussed [4, 5]. The VAS method has been used previously to derive so-called experience-based VAS values for children aged 10–11 years [9]. For adults, the VAS method has been used in several studies to derive experience-based value sets [10-15]. When predicted VAS values do not correspond to the 0 (dead) – 1 (full health) QALY scale required for the purpose of economic evaluation rescaling is needed [4]. To rescale the VAS value to 0 (dead) and 1 (full health) several approaches have been suggested; for example, simply by asking the respondent to place ‘dead’ on the scale [11, 16, 17]. However, recent theoretical assumptions for anchoring the VAS at ‘dead’ have been challenged [16]. Instead of anchoring the VAS at ‘dead’ it has been suggested to use the value of the worst health state defined in the descriptive system of an instrument [16]. To use the VAS for cost-utility analyses has been discussed by Parkin & Devlin [18], presenting arguments for and against its use in economic evaluation, as well as presenting shortcomings with the commonly used TTO and SG methods. However, the authors emphasise the need to carry out empirical research to challenge the dominant preconceptions against the use of the VAS in cost-utility analyses [18]. In addition to deciding which valuation method to use, there is an ongoing debate with regard to who should value health states. For adults, the two main directions are experience-based values, which are derived from people who are currently experiencing the health state they are valuing, and valuation of described (hypothetical) health states, which is when people are asked to imagine a health state and give it a value [19, 20]. Experience-based values require the target group, for the EQ-5D-Y young people, to perform the valuation. Results have differed when comparing preferences of adults and adolescents for described health states. Prevolnik Rupel et al. found that the relative importance of different dimensions was similar [21], while Dalziel et al. [22], found differences in the Australian sample as adolescents valued the mood dimensions as worst and adults valued pain/discomfort as worst [22]. In 2020, a standardised valuation protocol for the EQ-5D-Y-3L was developed to give guidance to ways in which to derive values for this youth version of the instrument to enable its use in economic evaluations [23]. According to this protocol, values for the EQ-5D-Y-3L should be elicited from an adult general population who are asked to value health states for a 10-year-old child with the TTO and DCE methods. So far, two value sets, following the guidance from the protocol [23], have been published, for Slovenia [24] and for Japan [25]. A considerable difference between how hypothetical value sets are derived for the adult version of the EQ-5D instrument [26] compared to the standardised protocol for the EQ-5D-Y-3L [23], is the applied child perspective. This difference might influence QALY weights and hence reimbursement decisions [27]. There has been an increase in studies including QALY weights for children [28] and a review of technology assessments to the National Institute for Health and Care Excellence (NICE) revealed a variety of methods being used to derive these QALY weights [29]. Clearer guidelines have been requested to help facilitate choices for decision makers [23, 30], including discussions about methods involving the state dead in the valuation task. In Sweden, for adults, the Dental and Pharmaceutical Benefits Agency (TLV) who decides on subsidy of pharmaceuticals, prefers values from persons experiencing the health state in question [31, 32]. The view regarding whose preferences and which perspective to adopt can be considered normative [19, 20], but clearer guidance is warranted [30]. Previous studies indicate that values for the EQ-5D-Y-3L instrument are dependent on the choice of method, for example Kreimeier et al. [7] showed that the TTO and DCE methods yielded higher mean values for children’s health states compared to adults’, while the opposite was found by Kind et al. [33] using the VAS method. Regardless of the valuation method and what perspective to use, to support researchers on how and what to report when conducting a valuation study for adults, a Checklist for Reporting Valuation studies (CREATE) has been developed [34]. These authors also stressed that there is no consensus in the scientific community regarding which method to use in a valuation study; hence, valuation methods are still under development. The aim of the present study was to explore EQ-5D-Y-3L experience-based VAS values derived among adolescents.

Methods

Materials and Study Population

EQ-5D-Y-3L and EQ VAS were included in the cross-sectional population survey Life & Health—Young People 2014, in Region Örebro, Sweden, distributed to adolescents aged 13–18 years. Åström et al. [35] have presented population data for EQ-5D-Y-3L based on the same survey, which included the EQ-5D-Y-3L Swedish version and questions on socio-demography, living conditions and health-related behaviours. There were 60–80 questions depending on the age, where older respondents also answered questions for example on alcohol use. In the current study, data are used to explore experience-based VAS values for EQ-5D-Y-3L health states. The Regional Ethical Review Board in Uppsala granted ethical permission (Dnr: 2013/459).

The EQ-5D-Y-3L and the Visual Analogue Scale (EQ VAS)

The EQ-5D-Y-3L is a generic HRQoL instrument, developed from the adult version of the instrument to be suitable for children and adolescents aged 8–15 years [2, 3]. The EQ-5D-Y-3L covers five dimensions of health ‘mobility’, ‘looking after myself’, ‘doing usual activities’, ‘having pain or discomfort’, and ‘feeling worried, sad or unhappy’, with three severity levels (no problems, some problems, a lot of problems) for each dimension. In addition to the descriptive system, the EQ-5D-Y-3L consists of the EQ VAS, where the child or adolescent rates his/her own overall health between 0 (worst) and 100 (best) imaginable health [3].

Data Analysis

Regression analyses were performed on individual data with VAS value as the dependent variable. The variables and the definition of models are presented in Table 1. The VAS value was used as the given number between 0–100 indicated by the respondent. Two dummy variables for each of the five EQ-5D-Y-3L dimensions were created representing the main effects. The dummy variable for level 2 represents the increment from level 1 (no problems) to level 2 (some problems); the dummy variable for level 3 represents the increment from level 2 (some problems) to level 3 (a lot of problems) (Table 1). We tested interaction variables that represent the occurrence of severity levels in at least one dimension which would potentially give an additional decrement to the predicted VAS values: if severity level 2 or 3 (N2); if severity level 3 (N3).
Table 1

Definition of variables and models

VariableDefinition
MOB21 if mobility at level 2 or 3; 0 otherwise
MOB31 if mobility at level 3; 0 otherwise
LAM21 if looking after myself at level 2 or 3; 0 otherwise
LAM31 if looking after myself at level 3; 0 otherwise
DUA21 if doing usual activities at level 2 or 3; 0 otherwise
DUA31 if doing usual activities at level 3; 0 otherwise
HPD21 if having pain or discomfort at level 2 or 3; 0 otherwise
HPD31 if having pain or discomfort at level 3; 0 otherwise
FWSU21 if feeling worried sad or unhappy at level 2 or 3; 0 otherwise
FWSU31 if feeling worried sad or unhappy at level 3; 0 otherwise
N21 if any dimension at level 2 or 3; 0 otherwise
OLS models on EQ-5D-Y-3LFunctions
Model 1f (MOB2 MOB3 LAM2 LAM3 DUA2 DUA3 HPD2 HPD3 FWSU2 FWSU3)
Model 2f (MOB2 MOB3 LAM2 LAM3 DUA2 DUA3 HPD2 HPD3 FWSU2 FWSU3 N2)
GLMs on EQ-5D-Y-3LFunctions
Model 3f (MOB2 MOB3 LAM2 LAM3 DUA2 DUA3 HPD2 HPD3 FWSU2 FWSU3)
Model 4f (MOB2 MOB3 LAM2 LAM3 DUA2 DUA3 HPD2 HPD3 FWSU2 FWSU3 N2)

GLM generalized linear models, OLS ordinary least squares

Definition of variables and models GLM generalized linear models, OLS ordinary least squares Ordinary least-squares (OLS) regressions were estimated with the main effects (Model 1); subsequently the interaction variables were entered with the N2 being statistically significant (Model 2). In all OLS models robust Standard Errors (SE) were reported because of potential heteroscedasticity. In addition to OLS, generalized linear models (GLMs) were tested with a binomial distribution: Model 3 with the main effects and Model 4 with the significant N2 term. The GLMs were tested as they were shown to provide better predictive performance than OLS in the creation of experience-based VAS value sets for EQ-5D-3L and EQ-5D-5L in Germany [12, 13], and tested in the development of an experience-based VAS value set for EQ-5D-5L in Sweden [14]. The N3 variable was not statistically significant in either the GLMs or the OLS models (results not shown). To assess the different models the primary consideration was to confirm that the decrement in VAS value increased as problems reported in the different dimensions increased, known as monotonic consistency. Model 1 and Model 2 were further investigated by comparing the goodness of fit of the models. Regarding GLM, all coefficients in Model 3 and Model 4, except the coefficients for LAM3 and DUA3, were statistically significant and these models were also considered for further investigation. Predicted VAS values were compared with the observed VAS values by calculation of mean absolute error (MAE), root mean square error (RMSE) and Spearman’s rank correlation coefficients, where higher correlations and lower MAE and RMSE indicate a better model fit [36]. MAE, RMSE and Spearman’s rank correlation were investigated including health states reported by more than five and ten respondents, respectively. For the OLS models, adjusted R2 was assessed with higher values indicating that the model explains a larger percentage of the variation in the dependent variable, i.e., the VAS value. For the GLM models, Akaike information criterion (AIC) and Bayesian information criterion (BIC) were considered to assess the quality of models, where lower values indicated a better model fit [36]. Making the choice of the final model to use for the calculation of the VAS values for the EQ-5D-Y-3L, the criteria of monotonicity, goodness of fit, simplicity of the model and understandability were considered [37]. A split sample, randomly divided (n = 3,216), validation was performed to test the robustness of Model 1. The VAS is anchored between 0 (worst) and 100 (best) imaginable health, which did not allow for anchoring between the 0 (dead) and 1 (full health) scale, a requirement for QALY calculations. One of many possible approaches to anchor the VAS values predicted by Model 1 at ‘dead’ and full health was explored by anchoring 0 at the predicted value for the worst health state in the EQ-5D-Y-3L descriptive system, i.e., 33333 and 100 at the predicted value for the best health state, i.e., 11111 [16]. A rescaled value for each health state (h) can be derived using the following formula: (Ratingh–Rating33333)/(Rating11111−Rating33333) [17]. Statistical analyses were performed using SAS version 9.4, using a 5% significance level.

Results

The response rate for the survey was 79.7% (n = 7,399). Respondents who had missing or ambiguous answers for sex (1.6%), age (0.9%), any of the EQ-5D-Y-3L dimensions (3.4%) or the EQ VAS (1.6%) were excluded, which resulted in a final sample of 6,468 participants. Respondents’ mean age was 15.9 years and girls made up half of the sample (49.5%) (Table 2). In total, 92 health states were reported from the total 243 possible health states. Mean EQ VAS score was 75.4. Most problems were reported in the mood dimensions, where 4.5% and 32.2% reported “a lot of” and “some” problems, followed by ‘pain/discomfort’ where 2.8% and 35.8% reported a lot of and some problems. With ‘doing usual activities’, 0.8% and 8.1% reported a lot of and some problems. Less than 5% reported some or a lot of problems in the dimensions ‘mobility’ and ‘looking after myself’.
Table 2

Characteristics of respondents in the survey Life & Health—young people 2014 (n = 6,468)

Variable%n
Sex
 Boys50.53,266
 Girls49.53,202
Mean age (years) [SD]15.9 [1.6]
 13−1434.22,213
 15−1634.22,210
 17−1831.62,045
Parents' occupational status
 One or both parents unemployed3.8244
 Both parents work73.24,737
 Missing23.01,487
Self-rated health
 Very good39.52,556
 Good43.82,832
 Neither good nor bad11.9772
Bad3.1200
 Very bad1.065
 Missing0.743
 Less than good self-rated health16.01,037
Mobility
 No problems95.36,167
 Some problems4.3277
 A lot of problems0.424
Self-care
 No problems99.06,405
Some problems0.853
 A lot of problems0.210
Usual activities
 No problems91.15,892
 Some problems8.1523
 A lot of problems0.853
Pain or discomfort
 No problems61.43,971
 Some problems35.82,314
 A lot of problems2.8183
Worried, sad or unhappy
 No problems62.34,029
 Some problems33.22,149
 A lot of problems4.5290
 Mean EQ VAS score [SD]75.4 [18.0]

EQ VAS EQ-5D-Y-3L and the visual analogue scale, SD standard deviation

Characteristics of respondents in the survey Life & Health—young people 2014 (n = 6,468) EQ VAS EQ-5D-Y-3L and the visual analogue scale, SD standard deviation The results from the OLS regression analysis, with robust SE, are presented in Table 3. In both OLS models, monotonicity was observed, namely a logical decrement in VAS value, with a decrement moving from level 1 to level 2 and additional decrement moving from level 2 to 3 for all dimensions. The largest decrements were observed in the dimension ‘feeling worried, sad or unhappy’, in Model 1, the coefficient for moving from level 1 to level 2 was 11.22, in absolute terms, and 13.32 for moving from level 2 to 3. The second largest decrements were found in the dimension ‘doing usual activities’, where in Model 1 the coefficient for moving from level 1 to 2 was 9.39. In Model 1, the coefficients for moving from level 2 to 3 in the dimensions ‘mobility’, ‘looking after myself’ and ‘doing usual activities’ were not statistically significant. The N2 variable added to Model 2 resulted in a statistically significant coefficient of 1.70. For Model 1 and Model 2, the adjusted R2 were the same (0.284) (Table 3). Similar pattern as for the OLS models were observed for the GLMs, with largest decrements observed in the dimension ‘feeling worried, sad or unhappy’. The coefficients for the N2 variable were statistically significant in Model 4. The second largest decrement was the coefficient representing moving from no problems to some problems (from level 1 to 2) in the dimension ‘doing usual activities’. AIC and BIC were lower in Model 4 compared to Model 3 (Table 3).
Table 3

Regression analyses on visual analogue scale (EQ VAS) values through ordinary least-squares (OLS) models and generalized linear models (GLMs), EQ-5D-Y-3L dimensions and incremental estimates (n = 6,468)

EQ-5D-Y-3L dimensionModel 1 OLS 11 parametersModel 2 OLS 12 parametersModel 3 GLM 11 parametersModel 4 GLM 12 parameters
Estimate incrementRSEp-valueEstimate incrementRSEp-valueEstimate incrementSEp-valueEstimate incrementSEp-value
Intercept83.220.24< 0.00181.740.82< 0.0011.580.00< 0.0011.610.01< 0.001
MOB2− 2.750.160.018− 2.621.170.025− 0.130.01< 0.001− 0.120.01< 0.001
MOB3− 3.784.480.399− 3.634.540.423− 0.170.05< 0.001− 0.160.050.001
LAM2− 7.632.570.003− 7.442.580.004− 0.350.03< 0.001− 0.330.03< 0.001
LAM3− 0.848.050.917− 0.648.110.938− 0.070.080.379− 0.060.080.425
DUA2− 9.390.92< 0.001− 9.250.92< 0.001− 0.430.01< 0.001− 0.430.01< 0.001
DUA3− 1.582.910.586− 1.892.910.517− 0.030.030.386− 0.040.030.151
HPD2− 4.710.44< 0.001− 3.770.71< 0.001− 0.260.01< 0.001− 0.180.01< 0.001
HPD3− 3.601.540.019− 3.871.540.012− 0.140.02< 0.001− 0.160.02< 0.001
FWSU2− 11.220.45< 0.001− 10.290.65< 0.001− 0.610.01< 0.001− 0.520.01< 0.001
FWSU3− 13.321.34< 0.001− 13.501.38< 0.001− 0.540.01< 0.001− 0.560.01< 0.001
N2− 1.700.860.048− 0.170.01< 0.001
Adjusted R20.2840.284
Root mean square error (RMSE)15.20415.200
Log likelihood115715115521
Akaike information criterion115737115545
Bayesian information criterion115812115626

RSE robust standard error, SE standard error

N2 = if level 2 or 3 in any of the dimensions

Regression analyses on visual analogue scale (EQ VAS) values through ordinary least-squares (OLS) models and generalized linear models (GLMs), EQ-5D-Y-3L dimensions and incremental estimates (n = 6,468) RSE robust standard error, SE standard error N2 = if level 2 or 3 in any of the dimensions To assess the models’ ability to predict VAS values, MAE, RMSE and Spearman’s rank correlation were considered. Regarding strength of correlation between observed and predicted VAS values, all models, OLS and GLMs, performed similar (r = 0.50) (Table 4). Similarly, results were also shown for all models regarding MAE and RMSE. Narrowing the analysis to include health states reported by more than five and more than ten respondents, respectively, did not result in stronger correlations or lower MAE or RMSE between observed and predicted VAS values in any of the models (Table 4).
Table 4

Mean absolute error (MAE), root mean square error (RMSE), Spearman rank correlation coefficients, between observed and predicted VAS values

Observation in each health stateNumber of health statesModel 1 OLSModel 2 OLSModel 3 GLMModel 4 GLM
MAERMSECorrelationMAERMSECorrelationMAERMSECorrelationMAERMSECorrelation
All920.11700.15200.4973*0.11690.15200.4974*0.11700.15210.4978*0.11690.15180.4976*
≥ 5350.12680.17890.4877*0.12680.17880.4875*0.12690.17910.4880*0.12680.17880.4877*
≥ 10240.12630.17810.4806*0.12620.17810.4804*0.12630.17690.4808*0.12620.17800.4806*

OLS, GLM generalised linear model, OLS ordinary least-squares, VAS visual analogue scale

*Significant at 0.01 level

Mean absolute error (MAE), root mean square error (RMSE), Spearman rank correlation coefficients, between observed and predicted VAS values OLS, GLM generalised linear model, OLS ordinary least-squares, VAS visual analogue scale *Significant at 0.01 level All four models performed similarly in terms of monotonicity and goodness of fit. However, in terms of simplicity and understandability, Model 1, the OLS model without dummies, was considered superior and the split validation showed that the performance of Model 1 was quite similar also with fewer participants (n = 3,216). A comparison between observed and predicted VAS values based on Model 1 is shown in Fig. 1.
Fig. 1

Mean observed VAS values compared to mean predicted VAS values based on Model 1 for health states with five or more observations (sorted by observed VAS value)

Mean observed VAS values compared to mean predicted VAS values based on Model 1 for health states with five or more observations (sorted by observed VAS value) Predicted VAS values and rescaled VAS values for all 243 EQ-5D-Y-3L health states can be found in the Online Resource Table S1. Calculation of VAS values for the EQ-5D-Y-3L health states based on Model 1, with the example of how to calculate the value for the health state 22323, is shown in Table 5, including comparison with two previous value sets [9, 10].
Table 5

Comparison between coefficients based on Model 1 with previous VAS value sets

Current study Model 1aBasic model Table 3, Wu et al. (2014) [9]Model 4 Table S4 Burström et al. (2014)b [10]
Intercept83.2285.7488.86
Mobility
 Level 2− 2.75− 2.50− 
 Level 3− 6.53− 3.86− 
 Level 2 and 3− − 9.77
Looking after myself
 Level 2− 7.63− 7.40− 
 Level 3− 8.47− 10.57− 
 Level 2 and 3− − 0.79
Doing usual activities
 Level 2− 9.39− 5.50− 12.11
 Level 3− 10.98− 10.47− 15.00
Having pain or discomfort
 Level 2− 4.70− 3.12− 6.71
 Level 3− 8.31− 11.28− 12.90
Feeling worried, sad or unhappy
 Level 2− 11.22− 4.40− 9.96
 Level 3− 24.54− 11.28− 23.72
 N3− − − 9.45

VAS visual analogue scale

aExample of calculation of VAS value for health state 22323 (83.22−2.75−7.63−10.98−4.70−24.54 = 32.62)

bThe adult version EQ-5D-3L was used, hence the dimensions were the following; mobility, self-care, usual activities, pain/discomfort and anxiety/depression

Comparison between coefficients based on Model 1 with previous VAS value sets VAS visual analogue scale aExample of calculation of VAS value for health state 22323 (83.22−2.75−7.63−10.98−4.70−24.54 = 32.62) bThe adult version EQ-5D-3L was used, hence the dimensions were the following; mobility, self-care, usual activities, pain/discomfort and anxiety/depression

Discussion

We have explored EQ-5D-Y-3L experience-based VAS values derived from a sample of 6,468 adolescents in Sweden. Data were derived from a survey administered via schools to all adolescents in one region in Sweden. The dimension ‘feeling, worried, sad or unhappy’ had the strongest association with the VAS values. This is in line with previous studies in the adult general population in Sweden, generating experience-based value sets for the EQ-5D-3L and the EQ-5D-5L; the mood dimension had the strongest association with both TTO and VAS values [10, 14]. The mood dimension was also found to have the strongest association with experience-based VAS values in a previous study in China [11]. To enable summarising the five dimensions and severity levels of the EQ-5D-Y descriptive system into a single index value and investigating how the dimensions of health might impact the overall health status differently, valuation of children’s and adolescents’ health states is needed [5]. Before the development of the standardised valuation protocol for EQ-5D-Y-3L [23], the first value set for the EQ-5D-Y-3L was derived from 10 to 11 years old children using the VAS [9]. However, the increased interest of using the EQ-5D-Y-3L in economic evaluations to assess interventions for children and adolescents have resulted in two recently developed value sets [24, 25]. Both these value sets were derived guided by the standardised valuation protocol for EQ-5D-Y-3L [23]. The approach suggested in the protocol, i.e., to ask adults to value health states for a 10-year-old child contrasts with our study and the study by Wu et al. [9], where youth themselves have valued their own health state, i.e., experience-based values were elicited. There is no consensus regarding what valuation method to use [34], and although arguments for which perspective to take have been presented in the literature [20], decision makers might not have taken a stand and maybe, there will not be a ‘one fit all solution’ with regard to perspective or valuation method across countries. When it comes to adults, TLV in Sweden prefer values to be elicited from persons in the health condition, primarily by using SG or TTO and secondarily by using a rating scale [31, 32]. In the value sets developed for the EQ-5D-Y-3L [24, 25] the most important dimension was ‘pain/discomfort’ followed by the dimension ‘feeling worried sad or unhappy’. In our study, second to the mood dimension the dimension ‘doing usual activities’ had the greatest association with the VAS value. The worst health state in the descriptive system of the EQ-5D-Y-3L is when the most severe level, a lot of problems, is reported in all dimensions, i.e., the health state 33333. In Shiroiwa et al. [25] the value was 0.29 for the health state 33333; in Prevolnik Rupel et al. [24] the value was − 0.69. In the present study the value for health state 33333 was 0.24, and in Wu et al. 0.38 [9] (both divided by 100 to enable comparison). The negative value observed in the Slovenian value set indicates that the health state 33333 is valued as being worse than ‘dead’. Generation of negative values when asking people to value described health state has been observed earlier [38]. However, a study by Bernfort et al. [39], showed that most people who lived in a health state defined by the UK value set as being worse than dead [38], did not perceive their own health state as worse than dead [39]. As value set differs regarding the range of scales, applying different value sets in economic evaluation will generate different results [27]. However, this should not limit the exploration of valuation methods and perspectives, which commonly do not yield negative values. The difference in values for health state 33333 between the study by Prevolnik Rupel et al. [24] and Shiroiwa et al. [25] is surprisingly large given that both studies are based on the standardised protocol [23]. One explanation to this could be cultural aspects [40, 41]. Differences in value sets have previously been observed, for example, when comparing value set for adults in Japan and UK, which resulted in the recommendation of a national value set for Japan [42]. It should be noted that the value for health state 33333 in the present study is much closer to the results in Shiroiwa et al. [15], even though different valuation methods and perspectives have been used in these two studies. When deriving value sets for the adult EQ-5D-3L in Slovenia, both the TTO and VAS methods were used, and substantial differences depending on valuation method were found [24]. Comparisons between value sets need to be done with caution, as there are several factors such as the valuation method, the perspective in terms of experience-based versus hypothetical health states, modelling, the age of the person valuing the health state that might influence the results [41]. An advantage with estimating experience-based values, i.e., asking people themselves to value the health states, is that we are capturing values that reflect aspects of HRQoL that are important for this age group. Hence, a strength of our study is that we have used self-reported data from adolescents aged 13–18 years. All adolescents in the specific age group were invited to participate, the study had a high response rate (79.7%), and was carried out in a region with a mixed socio-economic composition; hence, we have no reason to think that adolescents enrolled in this study would differ greatly from adolescents in other regions. Therefore, it could be suggested that the results may be generalisable to Sweden as a whole. Another strength of our study is that we have used the CREATE checklist [34] as a guidance on what to report from valuation studies. Even though the checklist was developed for adults, we consider the identified elements to be equally important for valuation of children and adolescent health states. The guidance by the checklist enhances the reproducibility of this study. Using the TTO method to value health states for children and adolescents comes with challenges [7]. Hence, exploring the use of the VAS, as also suggested by TLV [31, 32] as an option, contributes to insights regarding valuation of health states among the younger population. A limitation with our study was that the predicted VAS values are solely based on data from adolescents aged 13–18 years; hence, we lack information on data from the younger age group. In the study by Wu et al. [9], data were based on a sample of children aged 10–11 years and when compared to our results some differences can be observed. Another limitation was that we had no direct observation of the value for ‘dead’. In a population study in China [11] the mean VAS value for ‘dead’ was 4.5 and the median VAS value was 0.0. With a lack of such information in our study, instead we used the approach suggested by Sampson et al. [16], to rescale the predicted VAS values using the predicted value for the worst health state defined by the descriptive system as ‘dead’. However, it might be likely that the value for 33333 would not be the same as the value for ‘dead’ if such data could be collected in this group. In this study we present this as one possible way of anchoring VAS values, but further research regarding ways to anchor the VAS on the 0 to 1 scale that are required for QALY calculation are needed if the VAS were be used for the purpose of economic evaluation. One suggestion could be to have adults value ‘dead’ using another valuation method, this having been done previously for the CHU-9D instrument [43]. The challenges with anchoring are not per se restricted to when the VAS is used as a valuation method. When latent scale DCE values are derived, as suggested in the standardised protocol [23], the DCE values need to be anchored by values elicited with the TTO method. Using different perspectives in valuation studies among adults, valuation of experience-based versus described health states, might yield different results [44]. A different ordering of the most to the least important dimensions was seen when comparing the experience-based VAS values in the present study with the values where the general population of adults in Slovenia and Japan have valued EQ-5D-Y-3L health states described to them [24, 25]. However, the ordering was the same when comparing to the Swedish experience-based TTO and VAS value sets for EQ-5D-3L [10]. The intercept, namely the VAS value for health state 11111, in both the present study and in Wu et al. [9] is lower compared to Burström et al. [10]. This indicates that young respondents rate their own overall health lower than adults on the VAS even though they report no problems across all dimensions.

Conclusions

In this study, we have explored EQ-5D-Y-3L experience-based VAS values derived from adolescents. The dimension ‘feeling worried, sad or unhappy’ had the strongest association with VAS values, which is similar to what has been observed among the general adult population in Sweden when estimating value sets for both the EQ-5D-3L and EQ-5D-5L using both VAS and TTO methods. The findings suggest that it is possible for adolescents to value their own health state using the VAS, which makes it possible to capture aspects that are important for young people. Below is the link to the electronic supplementary material. Supplementary file1 (DOCX 33 kb)
It is desirable to derive information from the target group of young people, for whom decisions are made, on the importance of different health dimensions. There is an ongoing debate regarding which method and what perspective to use when eliciting values for EQ-5D-Y-3L health states.
This study explored EQ-5D-Y-3L experience-based VAS values among adolescents and found that the mood dimension had the strongest association with the VAS value.
The findings suggest that it is possible for adolescents to value their own health state using the VAS, which makes it possible to capture aspects that were important for young people in health state valuation.
  33 in total

1.  A value set for the EQ-5D based on experienced health states: development and testing for the German population.

Authors:  Reiner Leidl; Peter Reitmeir
Journal:  Pharmacoeconomics       Date:  2011-06       Impact factor: 4.981

2.  Valuation of EuroQol Five-Dimensional Questionnaire, Youth Version (EQ-5D-Y) and EuroQol Five-Dimensional Questionnaire, Three-Level Version (EQ-5D-3L) Health States: The Impact of Wording and Perspective.

Authors:  Simone Kreimeier; Mark Oppe; Juan M Ramos-Goñi; Amanda Cole; Nancy Devlin; Michael Herdman; Brendan Mulhern; Koonal K Shah; Elly Stolk; Oliver Rivero-Arias; Wolfgang Greiner
Journal:  Value Health       Date:  2018-08-08       Impact factor: 5.725

3.  A Swedish child-friendly pilot version of the EQ-5D instrument--the development process.

Authors:  Kristina Burström; Ann-Charlotte Egmar; Anna Lugnér; Margareta Eriksson; Magnus Svartengren
Journal:  Eur J Public Health       Date:  2010-04-29       Impact factor: 3.367

4.  An Experience-Based Value Set for the EQ-5D-5L in Germany.

Authors:  Reiner Leidl; Peter Reitmeir
Journal:  Value Health       Date:  2017-06-01       Impact factor: 5.725

5.  Developing adolescent-specific health state values for economic evaluation: an application of profile case best-worst scaling to the Child Health Utility 9D.

Authors:  Julie Ratcliffe; Terry Flynn; Frances Terlich; Katherine Stevens; John Brazier; Michael Sawyer
Journal:  Pharmacoeconomics       Date:  2012-08-01       Impact factor: 4.981

6.  Development of the EQ-5D-Y: a child-friendly version of the EQ-5D.

Authors:  Nora Wille; Xavier Badia; Gouke Bonsel; Kristina Burström; Gulia Cavrini; Nancy Devlin; Ann-Charlotte Egmar; Wolfgang Greiner; Narcis Gusi; Michael Herdman; Jennifer Jelsma; Paul Kind; Luciana Scalone; Ulrike Ravens-Sieberer
Journal:  Qual Life Res       Date:  2010-04-20       Impact factor: 4.147

7.  Assessment of children's own health status using visual analogue scale and descriptive system of the EQ-5D-Y: linkage between two systems.

Authors:  X Y Wu; A Ohinmaa; J A Johnson; P J Veugelers
Journal:  Qual Life Res       Date:  2013-07-27       Impact factor: 4.147

Review 8.  EQ-5D and the EuroQol Group: Past, Present and Future.

Authors:  Nancy J Devlin; Richard Brooks
Journal:  Appl Health Econ Health Policy       Date:  2017-04       Impact factor: 2.561

9.  Swedish experience-based value sets for EQ-5D health states.

Authors:  Kristina Burström; Sun Sun; Ulf-G Gerdtham; Martin Henriksson; Magnus Johannesson; Lars-Åke Levin; Niklas Zethraeus
Journal:  Qual Life Res       Date:  2013-08-22       Impact factor: 4.147

10.  Experience-based VAS values for EQ-5D-3L health states in a national general population health survey in China.

Authors:  Sun Sun; Jiaying Chen; Paul Kind; Ling Xu; Yaoguang Zhang; Kristina Burström
Journal:  Qual Life Res       Date:  2014-09-24       Impact factor: 4.147

View more
  1 in total

1.  Value Set for the EQ-5D-Y-3L in Hungary.

Authors:  Fanni Rencz; Gábor Ruzsa; Alex Bató; Zhihao Yang; Aureliano Paolo Finch; Valentin Brodszky
Journal:  Pharmacoeconomics       Date:  2022-09-20       Impact factor: 4.558

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.